Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

Chronic Obstructive Pulmonary Disease II: Emphysema

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Association between a novel regulatory genetic variants and lung cancer risk in Chinese: a two-stage case-control study].

Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi·2021

Same author

[Study of the association between interleukin-1 polymorphisms and genetic susceptibility of coal workers' pneumoconiosis and silicosis].

Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases·2018

Same author

Essential role of BETA2/NeuroD1 in development of the vestibular and auditory systems.

Genes & development·2000

Same author

Nov gene encodes adhesion factor for vascular smooth muscle cells and is dynamically regulated in response to vascular injury.

Arteriosclerosis, thrombosis, and vascular biology·2000

Same author

Changes of matrilin forms during endochondral ossification. Molecular basis of oligomeric assembly.

The Journal of biological chemistry·2000

Same author

Proteolytic degradation of tyrosine nitrated proteins.

Archives of biochemistry and biophysics·2000

Search research articles

Related Experiment Video

Updated: Jul 24, 2026

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica

Published on: October 28, 2022

[Research progress on pneumoconiosis markers based on multi-omics analysis].

Q Chen¹, W H Chen², M J Chu¹

¹Department of Epidemiology and Biostatistics, School of Public Health, Nantong University, Nantong 226019, China.

Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi = Zhonghua Laodong Weisheng Zhiyebing Zazhi = Chinese Journal of Industrial Hygiene and Occupational Diseases

|May 27, 2024

Summary

Identifying new markers for pneumoconiosis (lung fibrosis from dust) is crucial. Multi-omics approaches offer a promising strategy for early diagnosis and developing effective treatments for this condition.

Keywords:

Genomics Markers Metabolomics Pneumoconiosis Proteomics Ribonucleic acid Silicosis Single nucleotide polymorphism, SNPs Transcriptomics

More Related Videos

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust

Published on: January 6, 2023

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

Related Experiment Videos

Last Updated: Jul 24, 2026

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica

Published on: October 28, 2022

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust

A Silicosis Mouse Model Established by Repeated Inhalation of Crystalline Silica Dust

Published on: January 6, 2023

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

Area of Science:

Pulmonary Medicine
Biomarker Discovery
Genomics

Background:

The causes of pneumoconiosis are known, but its disease mechanisms and effective cures remain unclear.
Pulmonary fibrosis, a hallmark of pneumoconiosis, necessitates better diagnostic and therapeutic strategies.
Early identification of high-risk individuals and intervention targets are critical for managing dust-related lung diseases.

Purpose of the Study:

To review the progress in identifying pneumoconiosis markers using multi-omics.
To highlight the potential of multi-omics for understanding disease pathogenesis and developing interventions.
To provide foundational data for early prevention, diagnosis, and treatment of pneumoconiosis.

Main Methods:

Review of current research on pneumoconiosis markers.
Exploration of multi-omics technologies including genomics, transcriptomics, and proteomics.
Discussion of future directions involving integrated multi-omics and multi-stage analyses.

Main Results:

Multi-omics provides novel avenues for discovering potential pneumoconiosis biomarkers.
Systematic analysis of multi-omics data can identify key genes, proteins, and metabolic pathways.
Development of core regulatory networks can aid in screening for sensitive diagnostic and therapeutic markers.

Conclusions:

Multi-omics approaches are essential for a comprehensive understanding of pneumoconiosis pathogenesis.
Identifying key molecular players and networks can lead to sensitive markers for early diagnosis and treatment.
Further research combining multi-omics data is vital for advancing pneumoconiosis management.